Our Inception History
Journey through our company's evolution from startup to global pharmaceutical leader.
Key Achievements:
- Incorporation of Apothecon Pharmaceuticals Pvt. Ltd.
Key Achievements:
- Initiation of Commericial Operations Commencement of R&D Facility
Key Achievements:
- Formulation Facility for Oral Solids
Key Achievements:
- Inauguration of Manufacturing Facilitt for Small Volume APIs
- Inauguration of Manufacturing Facility for High Potent APIs
Key Achievements:
- Cleared First State FDCA & WHO GMP Audit
Key Achievements:
- First DMF Filing - Benztropine Mesylate USP
Key Achievements:
- First USFDA Site Audit Cleared
- First MHRA Site Audit Cleared
Key Achievements:
- Inauguration - Large Volume APIs Facility
- Expansion Project for API Manufacturing
- Manufacturing Block for Intermediates Inaugurated
Key Achievements:
- Launch - Famotidine for Oral Suspension, Diazepam Rectal Gel
- First RUSSIA Regulatory Site Audit Cleared
- Inauguration - Gel & Nasal Product Facility
Key Achievements:
- Introduction of Invitro Laboratory
- Expansion to Global Markets - US, Eurpoe, UK, etc.
Key Achievements:
- WHO GMP Audit Cleared for Diazepam Rectal Gel
- Social Responsibility - Village Adoption & Growth
Key Achievements:
- Inauguration of Peptide plant
- ANDA approvals for Miglustat Capsule 100mg / hydralazine HCL Injection / sevelamer HCL Tablets
The Leadership Team

Mr. Jayesh Kumar JoshiChairman & Non- Executive Director
We at Apothecon are always working to balance the demands of meeting global regulations and production costs, in an effort to produce the most innovative research and development while also producing safe, reliable drugs

Mr. Raja JayakumarPresident, COO & Executive Director
We at Apothecon are always working to balance the demands of meeting global regulations and production costs, in an effort to produce the most innovative research and development while also producing safe, reliable drugs

Mr. Dilipkumar ParmarCFO & Executive Director
We at Apothecon are always working to balance the demands of meeting global regulations and production costs, in an effort to produce the most innovative research and development while also producing safe, reliable drugs


